Arrowhead Pharmaceuticals Receives the US FDA’s Approval for Redemplo (Plozasiran) to Treat Familial Chylomicronemia Syndrome (FCS)

Shots: The US FDA has approved Redemplo as an adjunct to diet to reduce triglycerides (TGs) in adults with FCS; US availability is expected by year-end Approval was based on the P-III (PALISADE) trial assessing Redemplo (25mg & 50mg, SC, Q3M) vs PBO in 75 adults with genetically confirmed/clinically diagnosed FCS. Pts could join a…

ByRidhi Rastogi23 hours ago

THOUGHTSPOT

Everyday Environmental Hazards That Sabotage Your Circulation

Good circulation is like the lifeblood of your body—literally. It keeps everything moving smoothly, delivering oxygen and nutrients to your cells while whisking away waste products. But did you know that your everyday environment could be making it harder for your blood to flow freely? Let’s break down how environmental factors can mess with your…

ByArlette PachecoDecember 11, 2024

Arrowhead Pharmaceuticals Receives the US FDA’s Approval for Redemplo (Plozasiran) to Treat Familial Chylomicronemia Syndrome (FCS)

Everyday Environmental Hazards That Sabotage Your Circulation

Contact US

OUR INFORMATION

FOLLOW US